To view a copy of this licence, visit About this article Cite this article Farokhnia, M., McDiarmid, G.R., Newmeyer, M.N
However, their pharmacokinetic profiles, including bioavailability and potential toxicity, vary significantly and require careful consideration
By simultaneously improving glucose control and promoting weight loss, GLP-1 medications offer a unique therapeutic approach for individuals with type 2 diabetes, especially those who are overweight or obese
Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort
Also, L-carnitine has the potential to increase the utilisation of fat as a fuel source during exercise, sparing muscle glycogen and improving stamina